A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4245 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2755738
The present invention provides a method for the treatment of head trauma, traumatic brain injury, and/or dementia pugilistica comprising administering a therapeutically effective amount of (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4--oxadiazol-3- yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide.
La présente invention porte sur un procédé de traitement d'un trauma crânien, d'une lésion cérébrale traumatique et/ou d'une démence pugilistique comprenant l'administration d'une quantité thérapeutiquement efficace de (2R)-2-[[(4-chlorophényl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phényl]méthyl]amino]-5,5,5-trifluoropentanamide.
Gillman Kevin W.
Olson Richard E.
Starrett John E. Jr.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
A novel alpha-(n-sulfonamido)acetamide compound as an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A novel alpha-(n-sulfonamido)acetamide compound as an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel alpha-(n-sulfonamido)acetamide compound as an... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1833767